1. Home
  2. TVRD vs ALCO Comparison

TVRD vs ALCO Comparison

Compare TVRD & ALCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVRD
  • ALCO
  • Stock Information
  • Founded
  • TVRD 2017
  • ALCO 1960
  • Country
  • TVRD United States
  • ALCO United States
  • Employees
  • TVRD N/A
  • ALCO N/A
  • Industry
  • TVRD Biotechnology: Pharmaceutical Preparations
  • ALCO
  • Sector
  • TVRD Health Care
  • ALCO
  • Exchange
  • TVRD Nasdaq
  • ALCO Nasdaq
  • Market Cap
  • TVRD 246.5M
  • ALCO 224.5M
  • IPO Year
  • TVRD N/A
  • ALCO N/A
  • Fundamental
  • Price
  • TVRD $28.98
  • ALCO $32.27
  • Analyst Decision
  • TVRD Strong Buy
  • ALCO
  • Analyst Count
  • TVRD 2
  • ALCO 0
  • Target Price
  • TVRD $52.00
  • ALCO N/A
  • AVG Volume (30 Days)
  • TVRD 48.4K
  • ALCO 31.5K
  • Earning Date
  • TVRD 05-13-2025
  • ALCO 05-13-2025
  • Dividend Yield
  • TVRD N/A
  • ALCO 0.62%
  • EPS Growth
  • TVRD N/A
  • ALCO N/A
  • EPS
  • TVRD N/A
  • ALCO N/A
  • Revenue
  • TVRD N/A
  • ALCO $49,419,000.00
  • Revenue This Year
  • TVRD N/A
  • ALCO $22.90
  • Revenue Next Year
  • TVRD N/A
  • ALCO N/A
  • P/E Ratio
  • TVRD N/A
  • ALCO N/A
  • Revenue Growth
  • TVRD N/A
  • ALCO 23.36
  • 52 Week Low
  • TVRD $8.13
  • ALCO $24.20
  • 52 Week High
  • TVRD $34.31
  • ALCO $34.08
  • Technical
  • Relative Strength Index (RSI)
  • TVRD N/A
  • ALCO 71.62
  • Support Level
  • TVRD N/A
  • ALCO $31.55
  • Resistance Level
  • TVRD N/A
  • ALCO $32.42
  • Average True Range (ATR)
  • TVRD 0.00
  • ALCO 0.75
  • MACD
  • TVRD 0.00
  • ALCO 0.16
  • Stochastic Oscillator
  • TVRD 0.00
  • ALCO 95.14

About TVRD Tvardi Therapeutics Inc. Common Stock

Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.

About ALCO Alico Inc.

Alico Inc is a Florida-based agribusiness and land management company that primarily focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells primarily Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers most of the revenue as the firm's primary operating business unit.

Share on Social Networks: